Notice Title

Appointment to the Medicines Adverse Reactions Committee

Publication Date
15 Nov 2024

Tags

Medicines Act Appointments/reappointments Health

Notice Number

2024-go5888
Title
View PDF
File Type and Size
PDF (24 KB)

Pursuant to section 8 of the Medicines Act 1981, the Director-General of Health has, as per their delegated authority, appointed to the Medicines Adverse Reactions Committee:

Professor Lianne Parkin

as the Director of the New Zealand Pharmacovigilance Centre (ex officio member) with a term of office commencing on 1 December 2024.

Dated at Wellington this 8th day of November 2024.

Dr DIANA SARFATI, Director-General of Health.